The Enterprise Value as of November 2024 (TTM) for Greenwich LifeSciences, Inc. (GLSI) is 164.84M

According to Greenwich LifeSciences, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 164.84M. This represents a change of -3.20% compared to the average of 170.29M of the last 4 quarters.

Greenwich LifeSciences, Inc. (GLSI) Historical Enterprise Value (quarterly & annually)

How has GLSI Enterprise Value performed in the past?

The mean historical Enterprise Value of Greenwich LifeSciences, Inc. over the last ten years is 173.00M. The current 164.84M Enterprise Value has changed 9.43% with respect to the historical average. Over the past ten years (40 quarters), GLSI's Enterprise Value was at its highest in in the June 2021 quarter at 549.74M. The Enterprise Value was at its lowest in in the June 2019 quarter at 0.

Greenwich LifeSciences, Inc. (GLSI) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Greenwich LifeSciences, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Greenwich LifeSciences, Inc. (GLSI) Average Enterprise Value

How has GLSI Enterprise Value performed in the past?

The current Enterprise Value of Greenwich LifeSciences, Inc. (GLSI) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Greenwich LifeSciences, Inc. (GLSI) Enterprise Value vs. Peers

How is GLSI’s Enterprise Value compared to its peers?

Greenwich LifeSciences, Inc.’s Enterprise Value is greater than Reviva Pharmaceuticals Holdings, Inc. (28.64M), greater than Eyenovia, Inc. (57.71M), less than Immutep Limited (242.32M), less than Anavex Life Sciences Corp. (480.25M), greater than Virpax Pharmaceuticals, Inc. (1.60M), greater than Acurx Pharmaceuticals, Inc. (23.69M), greater than MediciNova, Inc. (38.55M), greater than NextCure, Inc. (21.96M), greater than Entera Bio Ltd. (55.86M), greater than X4 Pharmaceuticals, Inc. (20.60M), less than Terns Pharmaceuticals, Inc. (508.25M), less than Day One Biopharmaceuticals, Inc. (1.07B), greater than PDS Biotechnology Corporation (85.57M), less than Inozyme Pharma, Inc. (308.76M), less than Amylyx Pharmaceuticals, Inc. (0), less than Acumen Pharmaceuticals, Inc. (316.21M), greater than null (137.49M),

Build a custom stock screener for Greenwich LifeSciences, Inc. (GLSI) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Greenwich LifeSciences, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Greenwich LifeSciences, Inc. (GLSI) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Greenwich LifeSciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.